Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for depression and pain after cesarean section in women with sleep disorders
ChiCTR2500107756Phase 4Not yet recruiting
- Sponsor
- Wenzhou People's Hospital
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postpartum depression (PPD) and postoperative pain (2 arms), sponsored by Wenzhou People's Hospital. Primary endpoint: Incidence of postpartum depression on postoperative day 7. Planned start Aug 2025; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postpartum depression (PPD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2500107756.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107756.